MétaCan
Menu
← Back to cohort
Record W4205756976 · doi:10.1155/2007/165130

CAHR 2007 ‐ Oral Sessions

2007· article· en· W4205756976 on OpenAlexafffund
Viviane D. Lima, K. Johnson, Robert S. Hogg, Antonin Lévy, Richard Harrigan, Montaner Vancouver, British Columbia, Matthias Götte, Maryam Ehteshami, P Ronaldson, Catarina Tran, V Rasaiah, Bendayan Toronto, Stephanie Ramkumar, Darinka Sakac, N Branch, Barbara M. Lund, Lingwood Binnington, Kaitlin J. Soye, Sébastien Lainé, Carlos E Melendez-Peña, Patricia Landry, Jean‐Pierre Perreault, Anne Gatignol, R Nazari, M Ameli, Joshi Toronto, Ontario O, R Lalonde, Sylvie Trottier, D. William Cameron, Sharon Walmsley, Louis Flamand, G Mardh, P Borgeat, Nancy K. Higgins, Bernard F. Gibbs, D Colantonio, Brian M. Gilfix, A Boulerice, M Courchesne, Jean-Guy Baril, David Blank, Sheehan Montréal

Bibliographic record

VenueCanadian Journal of Infectious Diseases and Medical Microbiology · 2007
Typearticle
Languageen
FieldImmunology and Microbiology
TopicHIV Research and Treatment
Canadian institutionsToronto Public Health
FundersCanadian Institutes of Health ResearchOntario HIV Treatment NetworkCanadian Foundation for AIDS Research
KeywordsMedicineComputer science

Abstract

fetched live from OpenAlex

Objectives: To assess the impact of scaling up HAART on the HIV epidemic by simultaneously tracking the transmission dynamics of different sources of infection.Methods: We built a semi-deterministic dynamic model.The HIV natural history was defined by different infectivity strata: susceptible; primary infection; symptomatic phase defined by four viral load strata (<3, 3-4, 4-5, ≥5 log 10 copies/mL); and late stage.The model's deterministic component was responsible for predicting the number of new infections by increasing HAART coverage from 50% to 75%, 90% and 100%, and by changing the CD4 threshold for therapy initiation from ≤200 cells/mm 3 to ≤350 cells/mm 3 .The random component of this model was modeled using generalized additive models to take into account the effect of HAART, adherence, resistance and other key clinical and demographic factors on the distribution of individuals amongst infectivity strata over time.The probability of emergence of resistance during the course of therapy was modeled using logistic regression.Results: Our model predicts that within 25 years, given the current guidelines and adherence level (78.5%), the cumulative number of new infections averted by increasing the number of people on treatment from 50% to 75%, 90% and 100% is, respectively, 3108, 4776, and 5701.The greatest impact was on the new infections driven by injection drug use.These numbers are further stratified by different adherence levels.A beneficial effect was also seen in the worst case scenarios -high probability of developing resistance, and high virulence because of low adherence levels.Conclusions: Higher HAART usage was inevitably succeeded by a small increase in the prevalence of individuals carrying drug resistant virus driven by imperfect adherence and consequently high viral load.However, the overall benefit of expanding the access to HAART, as a powerful prevention strategy, was overwhelmingly substantial in reducing the growth of the epidemic.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesInsufficient payload (model declined to judge)
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: Other
Teacher disagreement score0.233
Threshold uncertainty score0.332

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0040.001
Open science0.0020.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.7670.548

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.258
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2007
Admission routes2
Has abstractyes

Explore more

Same venueCanadian Journal of Infectious Diseases and Medical Microbiology→Same topicHIV Research and Treatment→French-language works237,207→